February 2026 in “Psychiatria” Stress and emotional suppression can cause hair loss, so addressing both mental and physical health is important.
February 2026 in “International Journal of Homoeopathic Sciences” Homeopathic treatment with Arsenicum album improved keratosis pilaris symptoms in one case.
January 2026 in “Scientific Reports” Spiritual well-being improves quality of life for Palestinian women with breast cancer.
January 2026 in “Annals of dermatological science.” Stem cells can effectively regrow hair in women with hair loss.
January 2026 in “Clinical Journal for Nurse Practitioners in Women s Health” Pregnancy can cause skin changes, some harmless and others risky, needing careful management.
January 2026 in “Industrial Psychiatry Journal” Dengue fever can cause significant mental health issues like anxiety and depression.
Ayurveda-based care may improve quality of life for breast cancer patients without serious side effects.
December 2025 in “The Journal of Clinical Psychiatry” Finasteride is not proven to cause depression or suicide, and careful patient monitoring is advised.
Barbers trained in hair loss can better support and refer clients with alopecia.
November 2025 in “OPAL (Open@LaTrobe) (La Trobe University)” Androgenetic alopecia negatively impacts mental health, suggesting a need for psychological support in treatment.
Spiritual well-being is crucial for improving quality of life in women with breast cancer.
October 2025 in “Journal of Mahatma Gandhi University of Medical Sciences and Technology” Amitriptyline can cause temporary hair loss, which stops after discontinuing the drug.
September 2025 in “European journal of clinical pharmacy” Aesthetic surgery improves body image and mental health, but pre-surgery psychological screening is important to manage expectations.
A unified approach is needed to better diagnose and manage Telogen Effluvium, focusing on education, empathy, and safe treatments.
July 2025 in “International Journal of Dermatology” Safe alopecia treatments for breastfeeding women are limited due to potential risks to infants.
June 2025 in “British Journal of Dermatology” Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.
June 2025 in “British Journal of Dermatology” Tofacitinib was more effective than methotrexate for treating alopecia areata.
June 2025 in “Clinical Cancer Research” Scalp cooling can effectively prevent hair loss during chemotherapy in pregnancy.
May 2025 in “Life Studies” Lung cancer patients on immunotherapy and chemotherapy often experience severe fatigue, drowsiness, and appetite loss.
Ritlecitinib is a new treatment for severe hair loss in people 12 and older.
May 2025 in “International Journal of Nursing Education and Research” Hyperandrogenism causes significant physical and emotional challenges, needing better understanding and support.
May 2025 in “Oxford Academix (Oxford)” Dermatology trainees lack standardized guidelines and education for treating testosterone-induced skin conditions in transmasculine individuals.
A six-year-old girl with extra hair on her elbows was treated with hair removal methods.
May 2025 in “International Journal of Research Publication and Reviews” The Unani System of Medicine offers treatments for managing diffuse hair loss caused by stress and nutritional deficiencies.
February 2025 in “International Journal For Multidisciplinary Research” Addressing hair loss's psychological effects with mental health support is crucial for cancer survivors.
January 2025 in “Therapeutic Advances in Medical Oncology” Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.
December 2024 in “Brazilian Journal of Hair Health” Treating both bipolar disorder and hair-related BDD with psychiatric medications improved the patient's symptoms.
October 2024 in “Journal of the Endocrine Society” Leydig cell tumors can cause high testosterone and symptoms in postmenopausal women, and removing them improves symptoms.
August 2024 in “Indian Journal of Dermatology Venereology and Leprology” The book provides comprehensive treatment strategies for female hair loss.
June 2024 in “Journal of Clinical Oncology” Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.